Moleculin Biotech Inc. (MBRX) Business News Sept. 08, 2025, 12:30 UTC Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia Full text
There are no comments here yet...